As Introduced
Underlined text would be added to current law. Struck-through text would be removed.
Skip to main content
Kansas Legislature
kslegislature.gov
menu
Home
House
account_balanceAbout the House
groupsRepresentatives
campaignEvents
chairSeating Chart
auto_storiesJournals & Calendars
manage_accountsChief Clerk of the House
gavelRules
Senate
account_balanceAbout the Senate
groupsSenators
campaignEvents
assignment_indAppointments
chairSeating Chart
auto_storiesJournals & Calendars
manage_accountsSecretary of the Senate
gavelRules
Committees
groupsCommittees
eventHearing Schedule
handshakeConference Committee Schedule
Measures & Laws
gavelAll Measures
account_balanceHouse Measures
account_balanceSenate Measures
account_balanceVotes
topicSubject Index
summarizeReports
menu_bookStatutes
schoolHow a Bill Becomes Law
menu_bookLegislative Procedure Manual
Today
campaignLive Floor Activity
videocamHouse Video
videocamSenate Video
live_tvStatehouse Live & Archive
smart_displayYouTube Channel
Resources
Archive
Search
description
Go to bill or resolution
arrow_forward
A−
A+
search
Search bills, resolutions, and statutes
help
(c)(d) For the purpose of such examination examinations, the 15commissioner of insurance or the persons appointed by the commissioner, 16for the purpose of making such examination shall have free unrestricted 17access to the books and papers of any such insurance company or 18pharmacy benefits manager that relate relates to its such insurance 19company's or pharmacy benefits manager's business and to the books and 20papers kept by any of its agents and may examine under oath, which the 21commissioner or the persons appointed by the commissioner are 22empowered to administer, the directors, officers, agents or employees of 23any such insurance company or pharmacy benefits manager in relation to 24its such insurance company's or pharmacy benefits manager's affairs, 25transactions and condition.26(d)(e) The commissioner may also examine or investigate any person, 27or the business of any person, in so far as such examination or 28investigation is, in the sole discretion of the commissioner, necessary or 29material to the examination of the insurance company or pharmacy 30benefits manager, but such examination or investigation shall not infringe 31upon or extend to any communications or information accorded privileged 32or confidential status under any other laws of this state.33(e)(f) In lieu of examining the financial condition of a foreign or alien 34insurance company or pharmacy benefits manager, the commissioner of 35insurance may accept the report of the an examination made by or upon 36the authority of the company's state of domicile or port-of-entry state until 37January 1, 1994. Thereafter, such reports as they relate to financial 38condition may only be accepted if:39(1) At the time of the examination, the insurance department 40conducting the examination was at the time of the examination accredited 41under the national association of insurance commissioners' financial 42regulation standards and accreditation program; or43(2) the examination is was performed under the supervision of an 1accredited insurance department, or with the participation of one or more 2examiners who are employed by such an accredited insurance department 3and who, after a review of the examination work papers and report, state 4under oath that the examination was performed in a manner consistent 5with the standards and procedures required by their such insurance 6company's insurance department.7(f)(g) Upon determining that an examination should be conducted, the 8commissioner or the commissioner's designee shall appoint one or more 9examiners to perform the examination and instruct them such examiner as 10to the scope of the examination. In conducting an examination of financial 11condition, the examiner shall observe those guidelines and procedures set 12forth in the version of the examiners' handbook adopted promulgated by 13the national association of insurance commissioners in effect at the time of 14such examination as announced by the commissioner pursuant to K.S.A. 1540-2,256, and amendments thereto. The commissioner may also employ 16such other guidelines or procedures as the commissioner may deem 17appropriate.18(g)(h) The refusal of any insurance company or pharmacy benefits 19manager, by its officers, directors, employees or agents, to submit to 20examination or to comply with any reasonable written request of the 21examiners shall be grounds for suspension or refusal of, or nonrenewal of 22any license or authority held by the company to engage in an insurance or 23other business subject to the commissioner's jurisdiction. Any such 24proceedings for suspension, revocation or refusal of any license or 25authority shall be conducted in accordance with the provisions of the 26Kansas administrative procedure act.27(h)(i) When making an examination under this act, the commissioner 28may retain attorneys, appraisers, independent actuaries, independent 29certified public accountants or other professionals and specialists as 30examiners, the reasonable cost of which shall be borne by the insurance 31company which or pharmacy benefits manager that is the subject of the 32examination.33(i)(j) Nothing contained in this act shall be construed to limit the 34commissioner's authority to:35(1) Terminate or suspend any examination in order to pursue other 36legal or regulatory action pursuant to the insurance laws of this state.; or37(j) Nothing contained in this act shall be construed to limit the 38commissioner's authority39(2) to use and, if appropriate, to make public any final or preliminary 40examination report in the furtherance of any legal or regulatory action 41which the commissioner may, in the commissioner's sole discretion, deem 42appropriate.43(k) (1) No later than 30 days following completion of the examination 1or at such earlier time as the commissioner shall prescribe, the examiner in 2charge shall file with the department a verified written report of 3examination under oath. No later than 30 days following receipt of the 4verified report, the department shall transmit the report to the insurance 5company or pharmacy benefits manager examined, together with a notice 6which shall afford such insurance company or pharmacy benefits 7manager examined a reasonable opportunity of not more than 30 days to 8make a written submission or rebuttal with respect to any matters 9contained in the examination report.10(2) Within 30 days of the end of the period allowed for the receipt of 11written submissions or rebuttals, the commissioner shall fully consider and 12review the report, together with any written submissions or rebuttals and 13any relevant portions of the examiners workpapers and enter an order:14(A) Adopting the examination report as filed or with modification or 15corrections. If the examination report reveals that the insurance company 16or pharmacy benefits manager is operating in violation of any law, 17regulation or prior order of the commissioner, the commissioner may order 18the insurance company or pharmacy benefits manager to take any action 19the commissioner considers necessary and appropriate to cure such 20violations; or21(B) rejecting the examination report with directions to the examiners 22to reopen the examination for purposes of obtaining additional data, 23documentation or information, and refiling pursuant to subsection (k); or24(C) call and conduct a fact-finding hearing in accordance with K.S.A. 2540-281, and amendments thereto, for purposes of obtaining additional 26documentation, data, information and testimony.27(3) All orders entered as a result of revelations contained in the 28examination report shall be accompanied by findings and conclusions 29resulting from the commissioner's consideration and review of the 30examination report, relevant examiner workpapers and any written 31submissions or rebuttals. Within 30 days of the issuance of the adopted 32report, the insurance company or pharmacy benefits manager shall file 33affidavits executed by each of its directors stating under oath that they 34have received a copy of the adopted report and related orders.35(4) Upon the adoption of the examination report, the commissioner 36shall hold the content of the examination report as private and confidential 37information for a period of 30 days except to the extent provided in 38paragraph (5). Thereafter, the commissioner may open the report for public 39inspection so long as no court of competent jurisdiction has stayed its 40publication.41(5) (A) Except as provided in paragraph (B), nothing contained in this 42act shall prevent or be construed as prohibiting the commissioner from 43disclosing the content of an examination report, preliminary examination 1report or results, or any matter relating thereto, at any time to:2(i) The insurance department of this or any other state or country;3(ii) law enforcement officials of this or any other state or agency of 4the federal government or any other country; or5(iii) officials of any agency of another country.6(B) The commissioner shall not share any information listed in 7paragraph (A) unless the agency or office receiving the report or matters 8relating thereto agrees in writing to hold it confidential and in a manner 9consistent with this act.10(6) In the event the commissioner determines that regulatory action is 11appropriate as a result of any examination, the commissioner may initiate 12any proceedings or actions as provided by law.13(7) All working papers, recorded information, documents and copies 14thereof produced by, obtained by or disclosed to the commissioner or any 15other person in the course of an examination made under this act including 16analysis by the commissioner pertaining to either the financial condition or 17the market regulation of a an insurance company or pharmacy benefits 18manager must be given confidential treatment and are not subject to 19subpoena and may not be made public by the commissioner or any other 20person, except to the extent otherwise specifically provided in K.S.A. 45-21215 et seq., and amendments thereto. Access may also be granted to the 22national association of insurance commissioners and its affiliates. Such 23parties must agree in writing prior to receiving the information to provide 24to it the same confidential treatment as required by this section, unless the 25prior written consent of the insurance company or pharmacy benefits 26manager to which it pertains has been obtained.27(8) Whenever it appears to the commissioner of insurance from such 28examination or other satisfactory evidence that the solvency of any such 29insurance company is impaired, or that it is doing business in violation of 30any of the laws of this state, or that its affairs are in an unsound condition 31so as to endanger its policyholders, the commissioner of insurance shall 32give the company a notice and an opportunity for a hearing in accordance 33with the provisions of the Kansas administrative procedure act. If the 34hearing confirms the report of the examination, the commissioner shall 35suspend the certificate of authority of such company until its solvency 36shall have been fully restored and the laws of the state fully complied with. 37The commissioner may, if there is an unreasonable delay in restoring the 38solvency of such company and in complying with the law, revoke the 39certificate of authority of such company to do business in this state. Upon 40revoking any such certificate the commissioner shall commence an action 41to dissolve such company or to enjoin the same from doing or transacting 42business in this state.43Sec. 9. K.S.A. 2025 Supp. 40-3821 is hereby amended to read as 1follows: 40-3821. (a) K.S.A. 40-3821 through 40-3828, and amendments 2thereto, and K.S.A. 2025 Supp. 40-3828a et seq., and amendments thereto, 3shall be known and may be cited as the pharmacy benefits manager 4licensure Kansas consumer prescription protection and accountability act.5(b) On and after January 1, 2023, a No person shall not perform, act 6or do business in this state as a pharmacy benefits manager unless such 7person has a valid license issued by the commissioner pursuant to this act.8(c) This act shall apply to any pharmacy benefits manager that 9provides claims processing services, other prescription drug or device 10services, or both, to covered persons who are residents of this state.11(d) This act shall not apply to any pharmacy benefits manager that 12holds a certificate of registration as an administrator pursuant to K.S.A. 1340-3810, and amendments theretoThis act shall also apply to any audit of 14the records of a pharmacy conducted by a managed care company, third-15party payer, pharmacy benefits manager or any entity that represents a 16covered entity or health benefit plan and the registration of auditing 17entities.18(e) A license issued in accordance with the pharmacy benefits 19manager licensure Kansas consumer prescription protection and 20accountability act shall be nontransferrable.21Sec. 10. K.S.A. 2025 Supp. 40-3822 is hereby amended to read as 22follows: 40-3822. As used in this act:23(a) "Act" means the pharmacy benefits manager licensure Kansas 24consumer prescription protection and accountability act.25(b) "Affiliate" means a pharmacy, pharmacist or pharmacy 26technician which, either directly or indirectly through one or more 27intermediaries:28(1) Has an investment or ownership interest in a pharmacy benefits 29manager licensed under this chapter;30(2) shares common ownership with a pharmacy benefits manager 31licensed under this chapter; or32(3) has an investor or ownership interest holder that is a pharmacy 33benefits manager licensed under this article.34(c) "Auditing entity" means a person that performs a pharmacy audit, 35including a pharmacy benefits manager, managed care organization or 36third-party payer.37(b)(d) "Commissioner" means the commissioner of insurance as 38defined by K.S.A. 40-102, and amendments thereto.39(c)(e) (1) "Covered entity" means:40(A) A nonprofit hospital or medical service corporation, health 41insurer, health benefit plan or health maintenance organization;42(B) a health program administered by a department or the state in the 43capacity of provider of health coverage; or1(C) an employer, labor union or other group of persons organized in 2the state that provides health coverage to covered individuals who are 3employed or reside in the state a health insurance company, health 4maintenance organization, hospital, medical or dental corporation, 5healthcare corporation, any entity that provides, administers or manages 6a self-funded health benefit plan including a governmental plan or any 7other entity that provides prescription drug coverages unless specifically 8excluded in paragraph (2).9(2) "Covered entity" does not include any:10(A) Self-funded plan that is exempt from state regulation pursuant to 11ERISA;12(B) plan issued for coverage for federal employees; or13(C) health plan that provides coverage only for accidental injury, 14specified disease, hospital indemnity, medicare supplement, disability 15income, long-term care or other limited benefit health insurance policies 16and contracts insurers that provide coverage under a policy of property or 17casualty insurance or workers compensation insurance.18(d)(f) "Covered person" means a member, policyholder, subscriber, 19enrollee, beneficiary, dependent or other individual participating in a 20health benefit plan.21(g) "Defined cost sharing" means a deductible payment, copayment 22or coinsurance amount imposed on an enrollee for a covered prescription 23drug under the enrollee's health plan. 24(e)(h) "Department" means the insurance department Kansas 25department of insurance.26(f)(i) "ERISA" means the federal employee retirement income 27security act of 1974.28(g)(j) "Health benefit plan" means the same as defined in K.S.A. 40-294602, and amendments thereto.30(h)(k) "Health insurer" means the same as defined in K.S.A. 40-4602, 31and amendments thereto.32(i) "Maximum allowable cost" or "MAC" means any term or 33methodology that a pharmacy benefits manager or a healthcare insurer 34may use to establish the maximum amount that a pharmacy benefits 35manager will reimburse a pharmacy or a pharmacist for generic 36drugs(l) "Misfill" means a prescription:37(1) That was not dispensed;38(2) error;39(3) that had a request by the pharmacy to authorize the filling of such 40prescription that was denied by the prescriber; or41(4) that had an extra dispensing fee charged.42(m) "National average drug acquisition cost" means the monthly 43survey of retail pharmacies conducted by the federal centers for medicare 1and medicaid services to determine the average acquisition cost for 2medicaid-covered outpatient drugs.3(n) "Nonproprietary drug" means a drug containing any quantity of 4any controlled substance or any drug that is required by any applicable 5federal or state law to be dispensed only by prescription.6(o) "Person" means an individual, partnership, corporation, 7organization or other business entity.8(p) "Pharmacy audit" means an audit conducted by or on behalf of 9an auditing entity of any records of a pharmacy for prescription or 10nonproprietary drugs dispensed by a pharmacy to a covered person.11(j)(q) "Pharmacy benefits management" means:12(1) Any of the following services provided with regard to the 13administration of the following pharmacy benefits:14(A) Mail service pharmacy;15(B) claims processing, retail network management and payment of 16claims to pharmacies for prescription drugs dispensed to covered 17individuals;18(C) clinical formulary development and management services;19(D) rebate contracting and administration;20(E) certain patient compliance, therapeutic intervention and generic 21substitution programs; or22(F) disease management programs involving prescription drug 23utilization; and24(2) (A) the procurement of prescription drugs by a prescription 25benefits manager at a negotiated rate for dispensation to covered 26individuals within this state; or27(B) the administration or management of prescription drug benefits 28provided by a covered insurance entity for the benefit of covered 29individuals.30(k)(r) "Pharmacy benefits manager" means a person, business or 31other entity that performs pharmacy benefits management. "Pharmacy 32benefits manager" includes any person or entity acting in a contractual or 33employment relationship for a pharmacy benefits manager in the 34performance of pharmacy benefits management for a covered entity. 35"Pharmacy benefits manager" does not include a covered insurance entity.36(l) "Person" means an individual, partnership, corporation, 37organization or other business entity(s) "Pharmacy record" means any 38record stored electronically or as a hard copy by a pharmacy relating to 39the provision of prescription or nonproprietary drugs, pharmacy services 40or other component of pharmacist care that is included in the practice of 41pharmacy as defined in K.S.A. 65-1626a, and amendments thereto.42(t) "Pharmacy services administration organization" means any 43entity that contracts with a pharmacy to assist with covered entity 1interactions and that may provide a variety of other administrative 2services, including contracting with pharmacy benefits managers on 3behalf of pharmacies and managing pharmacies' claims payments from 4covered entities.5(u) "Rebate" means any and all payments that accrue to a pharmacy 6benefits manager or such pharmacy benefits manager's health plan client, 7directly or indirectly, from a pharmaceutical manufacturer, including, but 8not limited to, discounts, administration fees, credits, incentives or 9penalties associated directly or indirectly in any way with claims 10administered on behalf of a health plan client. "Rebate" does not include 11any discount or payment that may be provided to or made to any 340B 12entity through such program.13Sec. 11. K.S.A. 2025 Supp. 40-3823 is hereby amended to read as 14follows: 40-3823. (a) No person shall act or operate as a pharmacy benefits 15manager without first obtaining a valid license issued by the 16commissioner.17(b) Each person seeking a license to act as a pharmacy benefits 18manager shall file with the commissioner an application for a license upon 19a form to be furnished by the commissioner. At a minimum, the 20application form shall include the following information:21(1) The name, address and telephone number of the pharmacy 22benefits manager;23(2) the name, address, official position and professional qualifications 24of each individual who is responsible for the conduct of the affairs of the 25pharmacy benefits manager, including all members of the board of 26directors, board of trustees, executive committee, other governing board or 27committee, the principal officers in the case of a corporation, the partners 28or members in the case of a partnership or association;29(3) the name and address of the applicant's agent for service of 30process in the state;31(4) the name, address, phone number, email address and official 32position of the employee who will serve as the primary contact for the 33department;34(5) a copy of the pharmacy benefits manager's corporate charter, 35articles of incorporation or other charter document;36(6) a any template contract including a dispute resolution process, 37that ultimately involves an independent fact finder between:38(A) The pharmacy benefits manager and the health insurer; or39(B) the pharmacy benefits manager and the pharmacy or a pharmacy's 40contracting agent; and41(7) an affidavit, executed by an officer or director of the pharmacy 42benefits manager affirming that any template contract submitted pursuant 43to this subsection is the accurate and complete contract used; and1(8) a network adequacy report on a form prescribed by the 2department through rules and regulations.3(c) A nonrefundable application fee in an amount of not to exceed 4$2,500. Not later than December 1 of each year, the commissioner shall set 5and cause to be published in the Kansas register such fee for the next 6calendar year.7(d) The licensee shall inform the commissioner, by any means 8acceptable to the commissioner, of any material change in the information 9required by this subsection within 90 days of such change. Failure to 10timely inform the commissioner of a material change may result in a 11penalty against the licensee in the amount of $500 an amount of not to 12exceed $2,000 per occurrence.13(e) Within 90 days after receipt of a completed application, the 14network adequacy report and the applicable license fee, the commissioner 15shall review the application and issue a license if the applicant is deemed 16qualified under this section. If the commissioner determines that the 17applicant is not qualified, the commissioner shall notify the applicant and 18shall specify the reason for the denial.19(f) (1) All documents, materials or other information and copies 20thereof in the possession or control of the department or any other 21governmental entity that are obtained by or disclosed to the commissioner 22or any other person in the course of an application, examination or 23investigation made pursuant to this act shall be confidential by law and 24privileged, shall not be subject to any open records, freedom of 25information, sunshine or other public record disclosure laws and shall not 26be subject to subpoena or discovery.27(2) The provisions of paragraph (1) shall only apply to the disclosure 28of the confidential documents described in paragraph (1) by the 29department or any other governmental entity and shall not be construed to 30create any privilege in favor of any other party.31(3) The provisions of this subsection shall expire on July 1, 2027, 32unless the legislature reviews and reenacts this provision pursuant to 33K.S.A. 45-229, and amendments thereto, prior to July 1, 2027.34Sec. 12. K.S.A. 2025 Supp. 40-3824 is hereby amended to read as 35follows: 40-3824. (a) Each pharmacy benefits manager license shall expire 36on March 31 of each year and may be renewed annually on the request of 37the licensee. The application for renewal shall be submitted on a form 38furnished by the commissioner and accompanied by a renewal fee of not to 39exceed $2,500. The application for renewal shall be in such form and 40contain such matters as the commissioner prescribes.41(b) (1) Within 90 days after receipt of a completed renewal 42application, the commissioner shall review the application and any 43relevant information received pursuant to the provisions of this act, 1including quarterly and annual reports. If the commissioner determines 2the application is incomplete or the pharmacy benefits manager is not in 3compliance with the act, the commissioner shall notify the applicant and 4shall specify the reason for the denial of the renewal application.5(2) If a registered auditing entity fails to provide a completed 6application for renewal by March 31, or if the license renewal fee is not 7paid by March 31, then a penalty fee shall be assessed in an amount of not 8to exceed $250. The auditing entity shall remit the renewal fee plus the 9penalty fee before the commissioner issues such auditing entity's 10registration renewal. 11(c) If a pharmacy benefits manager fails to provide a completed 12application for renewal by March 31, or if a license renewal fee is not paid 13by the prescribed date March 31, then the amount of the fee, plus a penalty 14fee shall be assessed in an amount of not to exceed $2,500 shall be paid. 15The pharmacy benefits manager's license may be revoked or suspended by 16the commissioner until the renewal fee and any penalty assessed has been 17paid.18(c) Any person who performs or is performing any pharmacy benefits 19management service shall be required to obtain a license as a pharmacy 20benefits manager from the commissioner not later than January 1, 2023, in 21order to continue to do business in Kansas. The pharmacy benefits 22manager shall remit the renewal fee plus the penalty fee before the 23commissioner issues such pharmacy benefits manager's license renewal.24(d) The pharmacy benefits manager's license may be revoked or 25suspended by the commissioner until the renewal fee and any penalty 26assessed has been paid.27(d)(e) Not later than December 1 of each year, the commissioner shall 28set and cause to be published in the Kansas register the fees required 29pursuant to this section for the next calendar year.30Sec. 13. K.S.A. 2025 Supp. 40-3825 is hereby amended to read as 31follows: 40-3825. (a) In accordance with the provisions of the rules and 32regulations filing act, K.S.A. 77-415 et seq., and amendments thereto, the 33commissioner may adopt, amend and revoke rules and regulations 34governing the administration and enforcement of this act, limited to:35(1)(a) The content of the application form;36(2)(b) the content of any other form or report required to implement 37this act; and38(3)(c) such other rules and regulations as the commissioner may deem 39necessary to carry out the provisions of this act.40(b) The commissioner shall adopt, amend and revoke all such 41necessary rules and regulations not later than July 1, 2023.42Sec. 14. K.S.A. 2025 Supp. 40-3826 is hereby amended to read as 43follows: 40-3826. (a) If the commissioner has reason to believe that a 1pharmacy benefits manager has been engaged in this state or is engaging 2in this state in activity that violates the pharmacy benefits manager 3licensure Kansas consumer prescription protection and accountability act, 4the commissioner shall issue and serve upon such pharmacy benefits 5manager a statement of the charges of any such violation and conduct a 6hearing thereon in accordance with the provisions of the Kansas 7administrative procedure act.8(b) If, after such a hearing, the commissioner determines that the 9pharmacy benefits manager charged has violated the act, the commissioner 10may, in the exercise of discretion, order any one or more of the following:11(1) (A) Payment of a monetary penalty in an amount of not more than 12to exceed $1,000 for each and every act or violation. The total of the 13monetary penalties for such violations shall not exceed $10,000;14(B) if the pharmacy benefits manager knew or reasonably should 15have known that such manager was in violation of this act, payment of a 16monetary penalty in an amount of not more than to exceed $5,000 for each 17and every act or violation. The total of the monetary penalties for such 18violations shall not exceed $50,000 in any six-month period;19(2) if such manager knew or reasonably should have known such 20person was in violation of this act, the suspension or revocation of the 21pharmacy benefits manager's license; or22(3) the assessment of any costs incurred as a result of conducting the 23administrative hearing authorized by the provisions of this section against 24the pharmacy benefits manager.25(c) As used in this section, "costs" includes witness fees, mileage 26allowances, any costs associated with reproduction of documents that 27become a part of the hearing record and expenses of making a record of 28the hearing.29(d) (1) If the deadline for filing a petition for review has expired and 30no such petition has been filed, the commissioner may reopen and modify 31or set aside any portion or the entirety of any administrative order issued 32under this section.33(2) The reopening of any such order may occur if, in the 34commissioner's opinion, the conditions of fact or law have changed to 35warrant such an action or if such an action is warranted in the public 36interest.37(e) In addition to any other penalty provided by this act, any person 38who acts as a pharmacy benefits manager without being licensed as 39required by this act shall be subject to a fine of $5,000 not to exceed 40$100,000 for the period in which the pharmacy benefits manager is found 41to be in violation.42Sec. 15. K.S.A. 2025 Supp. 40-3827 is hereby amended to read as 43follows: 40-3827. (a) There is hereby established in the state treasury the 1pharmacy benefits manager licensure fund. Such fund shall be 2administered by the commissioner for costs related to administering the 3pharmacy benefits manager licensing Kansas consumer prescription 4protection and accountability act. All expenditures from the pharmacy 5benefits manager licensure fund shall be made in accordance with 6appropriation acts upon warrants of the director of accounts and reports 7issued pursuant to vouchers approved by the commissioner or by the 8commissioner's designee.9(b) The commissioner shall remit all moneys received by or for the 10commissioner under the provisions of this act to the state treasurer in 11accordance with the provisions of K.S.A. 75-4215, and amendments 12thereto. Upon receipt of each such remittance, the state treasurer shall 13deposit the entire amount thereof in the state treasury and such amount 14shall be credited to the pharmacy benefits manager licensure fund.15Sec. 16. K.S.A. 2025 Supp. 40-3828a is hereby amended to read as 16follows: 40-3828a. (a) A pharmacy benefits manager's license may be 17revoked, suspended or limited, the licensee may be censured or placed 18under probationary conditions or an application for a license or for 19reinstatement of a license may be denied upon a finding that the:20(1) Applicant or licensee committed fraud or misrepresentation in 21applying for or securing an original, renewal or reinstated license;22(2) licensee has violated any lawful rule or regulation promulgated by 23the commissioner or violated any lawful order or directive of the 24commissioner previously entered by the commissioner;25(3) pharmacy benefits manager has engaged in fraudulent activity that 26constitutes a violation of state or federal law;27(4) licensee has failed to furnish any information legally requested by 28the commissioner to the commissioner or the commissioner's investigators 29or representatives, including information requested during an examination 30pursuant to section 4, and amendments thereto;31(5) pharmacy benefits manager has been determined by the 32commissioner to be in violation of or noncompliance with state or federal 33law; or34(6) pharmacy benefits manager has failed to timely submit a renewal 35application and the information required under K.S.A. 40-3824, and 36amendments thereto. In lieu of a denial of a renewal application, the 37commissioner may permit the pharmacy benefits manager to submit to the 38commissioner a corrective action plan to correct or cure any deficiencies; 39or40(7) pharmacy benefits manager has failed to timely submit the 41reporting required by section 3, and amendments thereto.42(b) This section shall be a part of and supplemental to the pharmacy 43benefits manager licensure Kansas prescription protection and 1accountability act.2Sec. 17. K.S.A. 40-3831 is hereby amended to read as follows: 40-33831. (a) This section shall be known and may be cited as the Kansas 4pharmacy patients fair practices act.5(b) As used in this section:6(1) "Covered person" means the same as defined in K.S.A. 40-3822, 7and amendments thereto.8(2) "Health carrier" means the same as defined in K.S.A. 40-2,195, 9and amendments thereto.10(3) "Pharmacy benefits manager" means the same as defined in 11K.S.A. 40-3822, and amendments thereto.12(c) (1) Co-payments(1) Copayments applied by a health carrier for a 13prescription drug may shall not exceed the total submitted charges by the 14network pharmacy.15(2) A pharmacy or pharmacist shall have the right to provide a 16covered person with information regarding the amount of the covered 17person's cost share for a prescription drug. Neither a pharmacy nor a 18pharmacist shall be proscribed by a pharmacy benefits manager from 19discussing any such information or for selling a more affordable 20alternative to the covered person if such an alternative is available.21(d)(b) (1) This section applies to any contract between a pharmacy 22benefits manager and a pharmacy, a pharmacy services administration 23organization or a group purchasing organization that is entered into or 24renewed on and after January 1, 2019.25(2) The provisions of this section shall not apply to any policy or 26certificate that provides coverage for any specified disease, specified 27accident or accident only coverage, credit, dental, disability income, 28hospital indemnity, long-term care insurance as defined by K.S.A. 40-292227, and amendments thereto, vision care or any other limited 30supplemental benefit nor to any medicare supplement policy of insurance 31as defined by the commissioner of insurance by rule and regulation, any 32coverage issued as a supplement to liability insurance, workers 33compensation or similar insurance, automobile medical-payment insurance 34or any insurance under which benefits are payable with or without regard 35to fault, whether written on a group, blanket or individual basis.36Sec. 18. K.S.A. 40-222, 40-3828, 40-3831, 65-16,121, 65-16,122, 65-3716,123, 65-16,124, 65-16,125 and 65-16,126 and K.S.A. 2025 Supp. 40-38202, 40-3821, 40-3822, 40-3823, 40-3824, 40-3825, 40-3826, 40-3827, 3940-3828a, 40-3829 and 40-3830 are hereby repealed.40Sec. 19. This act shall take effect and be in force from and after its 41publication in the statute book.
search
keyboard_arrow_up
keyboard_arrow_down
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
arrow_upward
Top
Kansas State Legislature
In-State: 1-800-432-3924
Out-of-State: 785-296-2149
Keywords
Enter any words to search bills, statutes, and documents.
water quality funding
Bill or Resolution Number
Type a number and press Enter to go directly to the detail page.
HB 2590 SCR 1611
Statute Number
68-102 72-3715
Exact Phrase
Wrap your query in quotes.
“rules of evidence”
Document Type
Prefix with a type to narrow results.
testimony: HB 2513 minutes: budget
Searching…
No results found.
search Search bills, resolutions, and statutes Home House About the House Representatives Events Seating Chart Journals & Calendars Chief Clerk of the House Rules Senate About the Senate Senators Events Appointments Seating Chart Journals & Calendars Secretary of the Senate Rules Committees All Committees Hearing Schedule Conference Committee Schedule Measures & Laws All Measures House Measures Senate Measures Votes Subject Index Reports Statutes How a Bill Becomes Law Legislative Procedure Manual Resources Today Live Floor Activity House Video Senate Video Statehouse Live & Archive YouTube Channel Archive Search- SB 360›
- SB 360 — As Introduced
Kansas Legislature
SB 360 — As Introduced
picture_as_pdf Download PDF Session of 2026SENATE BILL No. 360By Committee on Financial Institutions and Insurance1-221AN ACT concerning insurance; enacting the Kansas consumer prescription 2protection and accountability act; providing for the regulation of 3pharmacy benefits managers; requiring the registration of auditing 4entities; establishing procedures and requirements for the conduct of 5pharmacy audits, pharmacy benefits manager reporting and 6examinations; amending K.S.A. 40-222 and 40-3831 and K.S.A. 2025 7Supp. 40-202, 40-3821, 40-3822, 40-3823, 40-3824, 40-3825, 40-3826, 840-3827 and 40-3828a and repealing the existing sections; also 9repealing K.S.A. 40-3828, 65-16,121, 65-16,122, 65-16,123, 65-1016,124, 65-16,125 and 65-16,126 and K.S.A. 2025 Supp. 40-3829 and 1140-3830.1213Be it enacted by the Legislature of the State of Kansas:14New Section 1. (a) An auditing entity conducting a pharmacy audit 15under this act shall:16(1) Keep information collected during a pharmacy audit confidential, 17except that such auditing entity may share the information with the 18pharmacy benefits manager, the covered entity for which the audit is being 19conducted and any regulatory agency and law enforcement agency as 20required by law;21(2) provide the pharmacy being audited with at least 14 calendar days' 22prior written notice before conducting such audit unless both parties agree 23otherwise. If the pharmacy requests a delay of the audit, such pharmacy 24shall provide notice to the pharmacy benefits manager within 72 hours of 25receiving notice of the audit;26(3) accept paper or electronic signature logs documenting the delivery 27of prescription or nonproprietary drugs and pharmacist services to a health 28plan beneficiary or such beneficiary's caregiver or guardian;29(4) provide a complete list of reviewed pharmacy records to an 30authorized representative of the pharmacy prior to leaving the pharmacy 31after the on-site portion of the audit has been completed;32(5) (A) provide the pharmacy with a written preliminary report of the 33pharmacy audit. Such report shall:34(i) Be delivered to the pharmacy or the pharmacy's corporate parent 35within 60 calendar days after completion of the on-site portion of the 36pharmacy audit;1(ii) include contact information for the auditing entity that conducted 2the pharmacy audit and an appropriate and accessible contact person, 3including such person's telephone number, facsimile number, email 4address and the auditing entity name and address so that audit results, 5procedures and any discrepancies can be reviewed; and6(iii) include, but not be limited to, claim level information for any 7discrepancy found and total dollar amounts of claims subject to recovery; 8and9(B) a pharmacy shall have at least 30 calendar days following receipt 10of the preliminary audit report to respond to the findings of the preliminary 11report;12(6) deliver the final written report to the pharmacy or the pharmacy's 13corporate parent within 90 calendar days after completion of the pharmacy 14audit. Such report shall include any response provided to the auditing 15entity by the pharmacy or corporate parent and consider and address all 16such responses. The final audit report may be delivered electronically; and17(7) upon request of the plan sponsor, provide a copy of the final 18report to the plan sponsor, including the disclosure of any money recouped 19in the audit. The auditing entity shall provide a copy of the report to the 20commissioner upon request. Reports provided to the commissioner shall 21be confidential by law, shall not be subject to subpoena and may not be 22made public by the commissioner or any other person, except to the extent 23otherwise specifically provided in the Kansas open records act, K.S.A. 45-24215 et seq., and amendments thereto. 25(b) An auditing entity conducting a pharmacy audit as provided in 26this act may:27(1) Have access to a pharmacy's previous audit report only if the 28report was prepared by that auditing entity, except as otherwise provided 29by federal or state law; and30(2) not charge back, recoup or collect penalties from a pharmacy until 31the time to file an appeal of a final pharmacy audit has passed or the 32appeals process has been exhausted, whichever is later.33(c) An auditing entity conducting a pharmacy audit as provided in 34this act shall not:35(1) Compensate such entity's employees or contractors contracted to 36conduct a pharmacy audit based solely on the amount claimed or the actual 37amount recouped during such audit;38(2) during the first five days of any month, initiate or schedule a 39pharmacy audit for any pharmacy averaging more than 600 prescriptions 40filled per week without the express consent of the pharmacy;41(3) use extrapolation to calculate penalties or amounts to be charged 42back or recouped unless otherwise required by federal law;43(4) include dispensing fees in the calculation of overpayments unless 1a prescription is considered a misfill; and2(5) (A) seek any fine, charge back, recoupment or other adjustment 3for a dispensed product or any portion of a dispensed product unless one or 4more of the following has occurred:5(i) Fraud or other intentional and willful misrepresentation has been 6committed by the pharmacy, as evidenced by a review of the claims data, 7statements, physical review or other investigative method;8(ii) the pharmacy has dispensed a product in excess of the benefit 9design as established by the plan sponsor;10(iii) the pharmacy has not filled prescriptions in accordance with the 11prescriber's order; or12(iv) an actual underpayment or overpayment has been made to the 13pharmacy; and14(B) any fee, charge back, recoupment or other adjustment shall be 15limited to the actual financial harm associated with the dispensed product 16or portion of the dispensed product or the actual underpayment or 17overpayment, pursuant to subparagraph (A).18(d) A pharmacy audit that involves clinical judgment shall be 19conducted by or in consultation with a pharmacist. Such pharmacy audit 20shall not cover:21(1) A period of more than 24 months after the date that a claim was 22submitted by the pharmacy to the pharmacy benefits manager or covered 23entity unless a longer period is required by law; or24(2) more than 250 prescriptions. A refill does not constitute a separate 25prescription for the purposes of this paragraph.26(e) When a pharmacy audit is performed, a pharmacy may use:27(1) Authentic and verifiable statements or records, including, but not 28limited to, medication administration records of a nursing home, assisted 29living facility, hospital or healthcare provider with prescriptive authority to 30validate the pharmacy record and delivery; or31(2) any valid prescription, including, but not limited to, medication 32administration records, facsimiles, electronic prescriptions, electronically 33stored images of prescriptions, electronically created annotations or 34documentation of telephone calls from the prescribing healthcare provider 35or practitioner's agent to validate claims in connection with prescriptions 36or changes in prescriptions or refills of prescription or nonproprietary 37drugs. Documentation of an oral prescription order that has been verified 38by the prescribing healthcare provider shall be deemed to meet the 39provisions of this subsection for the initial audit review.40(f) A pharmacy that is the subject of a pharmacy audit may not be 41subject to a charge back or recoupment for a clerical or recordkeeping 42error in a required document or record, including a typographical or 43computer error, unless the error resulted in overpayment to the pharmacy. 1Such pharmacy may appeal a final audit report in accordance with 2procedures established by the entity conducting the pharmacy audit.3(g) If an identified discrepancy in a pharmacy audit exceeds $25,000, 4future payments made by the pharmacy benefits manager to the pharmacy 5in excess of such amount may be withheld pending adjudication of an 6appeal.7(h) No interest may accrue for any party during an audit period, 8beginning with the notice of the pharmacy audit and ending with the 9conclusion of the appeals process.10(i) Except for medicare claims, approval of drug, prescriber or patient 11eligibility upon adjudication of a claim may not be reversed unless the 12pharmacy or pharmacist obtained adjudication by fraud or 13misrepresentation of claims elements.14(j) The provisions of this section shall not apply to a pharmacy audit 15if:16(1) Fraud, waste, abuse or other intentional misconduct is indicated 17by physical review or review of claims data or statements; or18(2) other investigative methods indicate that the pharmacy is or has 19been engaged in criminal wrongdoing, fraud or other intentional or willful 20misrepresentation.21(k) This section shall be a part of and supplemental to the Kansas 22consumer prescription protection and accountability act.23New Sec. 2. (a) No person shall act or operate as an auditing entity 24without first registering with the commissioner. 25 (b) Each person seeking to register as an auditing entity shall file 26with the commissioner an application upon a form prescribed by the 27commissioner accompanied by a nonrefundable registration fee in an 28amount of not to exceed $500. At a minimum, the application form shall 29include the following:30(1) Identity, address and telephone number of the applicant;31(2) name, business address and telephone number of the contact 32person for the applicant; and33(3) federal employer identification number for the applicant, if 34applicable.35(c) The commissioner shall issue a certificate of registration to an 36applicant if the commissioner determines that the applicant has submitted 37a completed application and paid the required registration fee.38(d) The certificate of registration is nontransferable and shall 39prominently list the expiration date of the registration.40(e) Each auditing entity registration shall expire on March 31 of each 41year and may be renewed annually at the request of the pharmacy auditing 42entity on or before March 31 of each year. The application for renewal 43shall be submitted by the auditing entity on a form prescribed by the 1commissioner and accompanied by a renewal fee in an amount of not to 2exceed $250. 3(f) If a registered auditing entity fails to provide a completed 4application for renewal by March 31 or if the renewal fee is not paid by 5March 31, then a penalty fee shall be assessed in an amount of not to 6exceed $250. The auditing entity shall remit the renewal fee plus penalty 7fee before the commissioner shall issue such auditing entity's registration 8renewal. 9(g) An auditing entity's registration may be suspended by the 10commissioner until the renewal application has been received and the 11renewal fee and any penalty assessed has been paid.12(h) Not later than December 1 of each year, the commissioner shall 13set and cause to be published in the Kansas register the fees required 14pursuant to this section for the next calendar year.15(i) This section shall be a part of and supplemental to the Kansas 16consumer prescription protection and accountability act.17New Sec. 3. (a) Each pharmacy benefits manager shall:18(1) For each health plan or covered entity for which such pharmacy 19benefits manager provides pharmacy benefits management services, 20annually or more frequently upon the commissioner's request, report to the 21commissioner the aggregate:22(A) Amount of rebates received by the pharmacy benefits manager;23(B) amount of rebates distributed to each health plan or covered 24entity contracted with the pharmacy benefits manager;25(C) amount of rebates passed on to the enrollees of each health plan 26or covered entity at the point-of-sale that reduced such enrollees' 27applicable deductibles, copayments, coinsurance or other cost-sharing 28amounts;29(D) and individual amount paid by the health plan or covered entity to 30the pharmacy benefits manager for pharmacist services itemized by 31pharmacy, product and goods and services; and32(E) and individual amount that a pharmacy benefits manager paid for 33pharmacist services itemized by pharmacy, product and goods and 34services;35(2) annually, report to the commissioner and each contracted health 36plan or covered entity the aggregate difference between the amount that 37the pharmacy benefits manager reimbursed pharmacies and the amount 38that the pharmacy benefits manager charged such health plan; and39(3) (A) quarterly, report to the commissioner on all drugs appearing 40on the national average drug acquisition cost list that are reimbursed at 4110% and below the national average drug acquisition cost and all drugs 42that are reimbursed at 10% and above the national average drug 43acquisition cost. 1(B) For each drug in the report, the pharmacy benefits manager shall 2include:3(i) The month that the drug was dispensed;4(ii) the quantity of the drug dispensed; 5(iii) the amount that the pharmacy was reimbursed;6(iv) whether the dispensing pharmacy was an affiliate of the 7pharmacy benefits manager;8(v) whether the drug was dispensed pursuant to a government health 9plan; and 10(vi) the average national drug acquisition cost for the month that the 11drug was dispensed.12(C) The pharmacy benefits manager shall publish a copy of this 13report on the pharmacy benefits manager's publicly available website for at 14least 24 months. 15(D) This report shall be exempt from the confidentiality provisions of 16subsection (d).17(b) (1) Annually, each health benefit plan or covered entity shall:18(A) Report to the commissioner the aggregate amount of credits, 19rebates, discounts or other such payments received by the health benefit 20plan or covered entity from a pharmacy benefits manager or drug 21manufacturer; and22(B) disclose to the commissioner the extent to which such credits, 23rebates, discounts or other such payments were passed on to reduce 24insurance premiums or rates. 25(2) The commissioner shall consider the information in such report 26when reviewing any premium rates charged for any individual or group 27accident and health insurance policy as provided in K.S.A. 40-2215 and 2840-3209, and amendments thereto.29(c) The reports required by this section shall be filed electronically on 30a form and in a manner prescribed by the commissioner.31(d) With the exception of the report described in subsection (a)(3), all 32data and information provided by the pharmacy benefits manager, health 33plan or covered entity, pursuant to the reporting requirements established 34by this section, shall:35(1) Be considered proprietary and confidential; and 36(2) not be subject to disclosure under the Kansas open records act, 37K.S.A. 45-215 et seq., and amendments thereto.38(e) This section shall be a part of and supplemental to the Kansas 39consumer prescription protection and accountability act.40New Sec. 4. (a) The commissioner may examine the affairs of a 41pharmacy benefits manager for compliance with the requirements of this 42act.43 (b) Every examination conducted under this section shall follow the 1examination procedures and requirements provided in K.S.A. 40-222, and 2amendments thereto. The commissioner may assess the costs of the 3examination to the pharmacy benefits manager.4 (c) (1) A pharmacy benefits manager shall not be subject to the 5provisions of K.S.A. 40-222(a), and amendments thereto, pertaining to the 6frequency of financial examinations of insurers. 7(2) The commissioner may examine a pharmacy benefits manager, 8pursuant to this section, whenever the commissioner believes it is 9reasonably necessary to ensure compliance with this act.10(d) The information and data obtained by the commissioner from a 11pharmacy benefits manager under this section shall be considered 12confidential by law and exempt from disclosure in accordance with K.S.A. 1340-222, and amendments thereto, and shall not be subject to disclosure 14under the Kansas open records act, K.S.A. 45-215 et seq., and amendments 15thereto.16(e) This section shall be a part of and supplemental to the Kansas 17consumer prescription protection and accountability act. 18New Sec. 5. (a) A pharmacy benefits manager shall not:19(1) Collect from a pharmacy, pharmacist or pharmacy technician any 20cost share charged to a covered person that exceeds the total submitted 21charges by the pharmacy or pharmacist to the pharmacy benefits manager;22(2) (A) reimburse a pharmacy, pharmacist or pharmacy technician for 23a prescription drug or pharmacy service any amount that is less than the 24national average drug acquisition cost for the prescription drug or 25pharmacy service at the time that the drug is administered or dispensed, 26plus a professional dispensing fee that is the greater of $10.50 or the 27dispensing fee calculated pursuant to K.A.R. 30-5-94; or 28(B) if the national average drug acquisition cost is not available at the 29time that a drug is administered or dispensed, a pharmacy benefits 30manager shall not reimburse a pharmacy, pharmacist or pharmacy 31technician an amount that is less than the wholesale acquisition cost of the 32drug as defined in 42 U.S.C. § 1395w-3a(c)(6)(B) plus a professional 33dispensing that is the greater of $10.50 or the dispensing fee calculated 34pursuant to K.A.R. 30-5-94;35(3) reimburse a pharmacy or pharmacist for a prescription drug or 36pharmacy service any amount less than the amount that the pharmacy 37benefits manager would reimburse itself or an affiliate for the same 38prescription drug or pharmacy service; and39(4) not engage in any practice that:40(A) Includes imposing a point-of-sale fee or retroactive fee; or41(B) derives any revenue from a pharmacy or covered person in 42connection with performing pharmacy benefits management services. The 43provisions of this section shall not be construed to prohibit pharmacy 1benefits managers from processing deductibles or copayments approved 2by a covered person's health benefit plan.3(b) A pharmacy benefits manager shall:4(1) Charge a health benefit plan the same price for a prescription drug 5as such pharmacy benefits manager pays a pharmacy for the prescription 6drug; and7(2) for purposes of complying with the provisions of subsection (a)8(2), utilize the most recently published monthly national average drug 9acquisition cost as a point of reference for the ingredient drug product 10component of a pharmacy's reimbursement for drugs appearing on the 11national average drug acquisition cost list.12(c) (1) Any methodology utilized by a pharmacy benefits manager in 13connection with reimbursement shall be filed with the commissioner at the 14time of initial licensure and at any time thereafter that any methodology is 15changed by the pharmacy benefits manager. 16(2) A methodology shall not be subject to disclosure and shall be 17treated as confidential and exempt from disclosure under the Kansas open 18records act, K.S.A. 45-215 et seq., and amendments thereto. 19(3) Every filed methodology shall comply with the provisions of 20subsection (a)(2), and no pharmacy benefits manager shall enter into a 21contract with a pharmacy that provides for reimbursement methodology 22that is impermissible under the provisions of subsection (a)(2).23(d) (1) A covered individual's defined cost sharing for each 24prescription drug shall be calculated at the point of sale based on a price 25that is reduced by an amount equal to at least 100% of all rebates received 26or to be received in connection with the dispensing or administration of the 27prescription drug. 28(2) Any rebate greater than the defined cost sharing shall be passed 29on to the health plan to reduce premiums. Nothing in this act shall be 30deemed to preclude an insurer from decreasing a covered person's defined 31cost sharing by an amount greater than what is previously stated.32(e) The commissioner may order reimbursement to an insured, 33pharmacy or dispenser who has incurred a monetary loss as a result of a 34violation of this act.35(f) This section shall be a part of and supplemental to the Kansas 36consumer prescription protection and accountability act.37New Sec. 6. (a) If any provision of this act or application thereof to 38any person or circumstance is held invalid, such invalidity shall not affect 39other provisions or applications of this act that can be given effect without 40the invalid provision or application, and to this end the provisions of this 41act are declared to be severable.42(b) This section shall be a part of and supplemental to the Kansas 43consumer prescription protection and accountability act.1Sec. 7. K.S.A. 2025 Supp. 40-202 is hereby amended to read as 2follows: 40-202. Except as provided in the Kansas consumer prescription 3protection and accountability act, nothing contained in this code shall 4apply to:5(a) Grand or subordinate lodges of any fraternal benefit society that 6admits to membership only persons engaged in one or more hazardous 7occupations in the same or similar line of business or to fraternal benefit 8societies as defined in and organized under article 7 of chapter 40 of the 9Kansas Statutes Annotated, and amendments thereto, unless they be 10expressly designated;11(b) the employees of a particular person, firm, or corporation;12(c) mercantile associations that simply guarantee insurance to each 13other in the same lines of trade and do not solicit insurance from the 14general public;15(d) the Swedish mutual aid association of Rapp, Osage county, 16Kansas;17(e) the Scandia mutual protective insurance company of Chanute, 18Kansas;19(f) the Seneca and St. Benedict mutual fire insurance company of 20Nemaha county, Kansas;21(g) the mutual insurance system practiced in the Mennonite church, in 22accordance with an old custom, either by the congregation themselves or 23by special associations, of its members in Kansas;24(h) the Kansas state high-school activities association;25(i) the mutual aid association of the church of the brethren;26(j) a voluntary noncontractual mutual aid arrangement whereby the 27needs of participants are announced and accommodated through 28subscriptions to a monthly publication;29(k) a self-funded health plan established or maintained for its 30employees by the state or a subdivision of the state, a school district, any 31public authority or by a county or city government or any political 32subdivision, agency or instrumentality thereof; or33(l) a self-funded health plan established or maintained for its 34employees by a church or by a convention or association of churches that 35is exempt from tax under section 501 of the internal revenue code.36Sec. 8. K.S.A. 40-222 is hereby amended to read as follows: 40-222. 37(a) Whenever the commissioner of insurance deems it necessary but at 38least once every five years, the commissioner may make, or direct to be 39made, a financial examination of any insurance company in the process of 40organization, or applying for admission or doing business in this state. In 41addition, at the commissioner's discretion the commissioner may make, or 42direct to be made, a market regulation examination of any insurance 43company doing business in this state.1(b) Whenever the commissioner deems it necessary, the commissioner 2may make or direct to be made a financial examination or market 3regulation examination of any pharmacy benefits manager that conducts 4business in Kansas.5(c) In scheduling and determining the nature, scope and frequency of 6examinations of financial condition, the commissioner shall consider such 7matters as the results of financial statement analyses and ratios, changes in 8management or ownership, actuarial opinions, reports of independent 9certified public accountants and other criteria as set forth in the examiner's 10handbook adopted by the national association of insurance commissioners 11and in effect at the time of such examination as announced by the 12commissioner pursuant to K.S.A. 40-2,256, and amendments thereto, when 13the commissioner exercises discretion under this subsection.14300 SW 10th Ave, Topeka, KS 66612
Ad Astra Per Aspera
Kansas Legislative HotlineIn-State: 1-800-432-3924
Out-of-State: 785-296-2149
Government
- Legislators
- House
- Representatives
- Senate
- Senators
- Committees
Resources
- Bills & Measures
- Today
- Live
- Journals
- Calendars
- Archived Records
- Laws
- Search
- RSS Feeds
Support
- Contact Us
- Accessibility
- Privacy Policy
- Visit Us
Official text from the Kansas Legislature. Formatting has been adapted for reading on Ratifi.